pyridinolcarbamate has been researched along with Hepatitis A in 1 studies
Pyridinolcarbamate: A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408)
Hepatitis A: INFLAMMATION of the LIVER in humans caused by a member of the HEPATOVIRUS genus, HUMAN HEPATITIS A VIRUS. It can be transmitted through fecal contamination of food or water.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kozhukhova, EA | 1 |
| Iakushin, AI | 1 |
| Zakharova, VI | 1 |
| Mebel', BD | 1 |
| Larionov, GM | 1 |
1 other study available for pyridinolcarbamate and Hepatitis A
| Article | Year |
|---|---|
[Prodectin in the treatment of viral hepatitis].
Topics: Adolescent; Adult; Antiviral Agents; Carbamates; Hepatitis A; Humans; Kinins; Pyridinolcarbamate | 1983 |